Continuous Light Scattering for Protein Aggregation Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring protein aggregation in pharmaceutical and biotechnology industries are inefficient due to their intermittent nature and inability to provide continuous, real-time data, which is crucial for understanding the complex mechanisms and kinetics involved in protein aggregation, leading to issues like biologic unavailability and immune responses.
Innovation Solution
The development of a system that utilizes time-dependent light scattering signatures to continuously monitor protein aggregation, allowing for the identification of aggregation mechanisms by analyzing the weight average molecular weight over time and adjusting formulation conditions to optimize stability and prevent aggregation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If intermittent sampling methods like GPC are used to monitor protein aggregation, then measurement capability is provided, but continuous real-time monitoring is lost
Solution Approach 1:
The patent implements continuous monitoring of protein aggregation using light scattering techniques that provide uninterrupted real-time data collection. The system maintains continuous measurement of aggregation parameters without intermittent sampling, enabling observation of aggregation kinetics and mechanism transitions as they occur naturally in the protein solution.
2Loss of information
If discrete sampling methods are used, then individual aggregation data points are obtained, but the complex kinetics and mechanisms of aggregation cannot be fully understood
Solution Approach 1:
The system incorporates real-time feedback from continuous light scattering measurements to detect changes in aggregation mechanisms. By continuously monitoring scattering intensity and applying multivariate analysis, the system can identify transitions between different aggregation mechanisms (e.g., from monomer-to-dimer to oligomer formation) and provide feedback on formulation stability, enabling researchers to optimize conditions based on actual aggregation behavior rather than discrete snapshots.
3Quantity of substance
If multiple samples are tested using traditional methods, then comprehensive aggregation data can be collected, but the process becomes time-consuming and inefficient
Solution Approach 1:
The patent merges multiple measurement capabilities into a single continuous light scattering system that can simultaneously monitor aggregation in multiple samples or conditions. By combining real-time light scattering detection with automated data analysis, the system evaluates numerous formulation variants and stress conditions continuously, dramatically increasing the quantity of aggregation data collected per unit time compared to sequential discrete sampling methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables real-time monitoring and optimization of protein aggregation processes, enhancing the stability and effectiveness of protein-based drugs by distinguishing between different aggregation mechanisms and adjusting conditions to prevent unwanted aggregation.
Implementation Method 1
The formation of aggregates in solutions of therapeutic proteins... is a widespread and well recognized problem... One of the most widespread methods for investigating aggregation is Gel Permeation Chromatography (GPC)... Other discrete sampling methods for characterizing aggregation include fluorescence, differential scanning calorimetry (DSC), dynamic light scattering
Data Source
AI summary
Method, device, and system for identifying a model-based time dependent light scattering signature that includes receiving an experimental time dependent light scattering signature comprising experimental data descriptive of an average molecular weight of protein components in a solution over time. The method further includes identifying an Ansatz for evaluating the experimental time dependent light scattering signature, the Ansatz being an initial model-based time dependent light scattering signature, the initial model-based time dependent light scattering signature identifying at least one key variable. The method also includes adjusting the at least one key variable in the initial model-based time dependent light scattering signature until a final model-based time dependent light scattering signature is identified. In some instances, the final model-based time dependent light scattering signature identifies at least one protein aggregation mechanism.